Comparison of adverse events between cluster and conventional immunotherapy for allergic rhinitis patients with or without asthma: A systematic review and meta-analysis
American Journal of Otolaryngology - Head and Neck Medicine and Surgery Nov 21, 2019
Jiang Z, et al. - In this systematic review and meta-analysis, researchers ascertained if cluster schedule leads to a higher risk of local adverse reactions (LARs) and systemic adverse reactions (SARs) than cluster schedule does. The meta-analysis involved five observational studies and six interventional studies. No variations were obtained between the cluster and conventional schedules when analyzing SARs by the number of patients, delayed SARs, grade 2 SARs and LARs. In observational studies, analyzes of SARs by injection, grade 1 SARs and LARs by injection showed that cluster schedule had a lower risk of adverse events than conventional schedule. For AR individuals with or without asthma, cluster schedule is as safe as or even safer compared with conventional schedule.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries